BDF Gestion Acquires 22,825 Shares of GE HealthCare Technologies Inc. $GEHC

BDF Gestion bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 3rd quarter, HoldingsChannel reports. The institutional investor bought 22,825 shares of the company’s stock, valued at approximately $1,492,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of GEHC. TD Waterhouse Canada Inc. lifted its position in shares of GE HealthCare Technologies by 5.1% during the third quarter. TD Waterhouse Canada Inc. now owns 608,890 shares of the company’s stock worth $39,015,000 after purchasing an additional 29,752 shares in the last quarter. V Square Quantitative Management LLC boosted its stake in shares of GE HealthCare Technologies by 13.2% in the third quarter. V Square Quantitative Management LLC now owns 7,680 shares of the company’s stock valued at $502,000 after purchasing an additional 894 shares during the period. Assenagon Asset Management S.A. boosted its stake in shares of GE HealthCare Technologies by 1,606.2% in the third quarter. Assenagon Asset Management S.A. now owns 236,295 shares of the company’s stock valued at $15,447,000 after purchasing an additional 222,446 shares during the period. Mather Group LLC. grew its holdings in shares of GE HealthCare Technologies by 86.2% in the third quarter. Mather Group LLC. now owns 85,945 shares of the company’s stock valued at $5,618,000 after purchasing an additional 39,796 shares in the last quarter. Finally, Fortitude Family Office LLC grew its holdings in shares of GE HealthCare Technologies by 249.1% in the third quarter. Fortitude Family Office LLC now owns 597 shares of the company’s stock valued at $39,000 after purchasing an additional 426 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on GEHC shares. Hovde Group started coverage on shares of GE HealthCare Technologies in a research note on Friday, July 17th. They set a “market perform” rating and a $14.00 target price on the stock. Barclays raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Wednesday, October 7th. Needham & Company LLC restated a “buy” rating and issued a $93.00 price target on shares of GE HealthCare Technologies in a research note on Monday, October 5th. Wells Fargo & Company upped their price objective on GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an “overweight” rating in a research report on Thursday, July 30th. Finally, Piper Sandler reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a research report on Wednesday, July 29th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $78.35.

GE HealthCare Technologies Stock Down 0.2%

Shares of GE HealthCare Technologies stock traded down $0.15 on Monday, reaching $69.42. 588,561 shares of the company were exchanged, compared to its average volume of 4,240,208. The stock’s 50 day moving average price is $68.54 and its 200-day moving average price is $66.78. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.97. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a market cap of $31.36 billion, a P/E ratio of 15.93, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter last year, the company earned $1.06 earnings per share. The firm’s revenue was up 5.8% compared to the same quarter last year. As a group, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.93 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be issued a dividend of $0.04 per share. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. The ex-dividend date is Friday, October 23rd. This represents a $0.16 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.67%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc is a global medical technology company that develops and provides products, services and digital solutions for healthcare providers. Its offerings are designed to support the diagnosis, treatment and monitoring of patients across hospitals, outpatient facilities, imaging centers and other care settings.

The company’s portfolio includes medical imaging systems such as computed tomography, magnetic resonance imaging, molecular imaging, surgical imaging and X-ray equipment.